Wednesday, April 27, 2016 - Thursday, April 27, 2017 12:00 AM
At the conclusion of this activity, participants should be able to:
- Review pathology of neuroblastoma;
- Review molecular pathogenesis of neuroblastoma;
- Review molecular advances in neuroblastoma; and
- Review new clinical therapies in neuroblastoma.
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.